heparin
- Access DeniedMulticenter Randomized Evaluation of High Versus Standard Heparin Dose on Incident Radial Arterial Occlusion After Transradial Coronary AngiographyThe SPIRIT OF ARTEMIS StudyGeorge N. Hahalis, Marianna Leopoulou, et alJACC: Cardiovascular Interventions
- Access DeniedOutcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus HeparinA Report From the National Cardiovascular Data RegistryIon S. Jovin, Rachit M. Shah, et alJACC: Cardiovascular Interventions
- Access DeniedCombined Use of Bivalirudin and Radial Access in Acute Coronary Syndromes Is Not Superior to the Use of Either One SeparatelyMeta-Analysis of Randomized Controlled TrialsGeorge S. Mina, George F. Gobrial, et alJACC: Cardiovascular Interventions
- Access DeniedBivalirudin in Current PracticeMelius Abundare Quam Deficere?Marco Valgimigli, Giuseppe GargiuloJACC: Cardiovascular Interventions
- Access DeniedNovel Approaches for Preventing or Limiting Events (Naples) III TrialRandomized Comparison of Bivalirudin Versus Unfractionated Heparin in Patients at Increased Risk of Bleeding Undergoing Transfemoral Elective Coronary StentingCarlo Briguori, Gabriella Visconti, et alJACC: Cardiovascular Interventions
- Access DeniedFollow the DataBivalirudin (and Not Heparin Alone) During Percutaneous Coronary Intervention Provides the Best Clinical OutcomesGregg W. Stone, Roxana Mehran, et alJACC: Cardiovascular Interventions
- Access DeniedComprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary SyndromeEliano Pio Navarese, Volker Schulze, et alJACC: Cardiovascular Interventions
- Access DeniedIs Heparin an Acceptable Anticoagulant When Glycoprotein IIb/IIIa Inhibitors Are Not Used?Michael S. Lee, Seung-Woon Rha, et alJACC: Cardiovascular Interventions
- Access DeniedBleeding Avoidance in Transcatheter Aortic Valve ReplacementA Call to ACTion?Matthew I. Tomey, Roxana MehranJACC: Cardiovascular Interventions
- Access DeniedUse of Anticoagulant Agents and Risk of Bleeding Among Patients Admitted With Myocardial InfarctionA Report From the NCDR ACTION Registry–GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With the Guidelines)Mitul B. Kadakia, Nihar R. Desai, et alJACC: Cardiovascular Interventions
Pages
Advertisement